Wed, May 25, 2022
Tue, May 24, 2022
Mon, May 23, 2022
Sat, May 21, 2022
Fri, May 20, 2022
Thu, May 19, 2022

David Risinger Initiated (VRTX) at Hold and Held Target at $265 on, May 23rd, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. old-and-held-target-at-265-on-may-23rd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Risinger of SVB Leerink, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold and Held Target at $265 on, May 23rd, 2022.

David has made no other calls on VRTX in the last 4 months.



There are 11 other peers that have a rating on VRTX. Out of the 11 peers that are also analyzing VRTX, 5 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $267 on, Friday, May 6th, 2022
  • Brian Skorney of "Baird" Downgraded from Buy to Hold on, Friday, May 6th, 2022
  • Do Kim of "Piper Sandler" Maintained at Hold with Decreased Target to $242 on, Friday, May 6th, 2022
  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $240 on, Thursday, May 5th, 2022
  • Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Hold and Held Target at $250 on, Tuesday, May 3rd, 2022


These are the ratings of the 6 analyists that currently disagree with David


  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $278 on, Monday, May 9th, 2022
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $305 on, Friday, May 6th, 2022
  • Gena Wang of "Barclays" Maintained at Buy and Held Target at $291 on, Thursday, May 5th, 2022
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $322 on, Wednesday, April 27th, 2022
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $350 on, Monday, April 4th, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $275 on, Thursday, January 27th, 2022

Publication Contributing Sources